AIM2 and rectal cancer: In addition, AIM2-rs1103577 has been found protective role on risk of tuberculosis (Figueira et al., 2021), and rs2298803 in AIM2 was investigated in patients with rectal cancer and have no correlation with adverse events of postoperative chemoradiotherapy (Chen et al., 2023).